Member Login
Market Reports
 |
|
* Single License allows for report sharing within one company location.
CHINESE MARKET FOR CARDIOVASCULAR DEVICES FORECAST TO GROW 18% ANNUALLY THROUGH 2013, DRIVEN BY EXPANDED SERVICES AND PROCEDURES
The combination of a large, aging population and strong economic growth has focused significant attention on China as the health care market of the future. Reports and analyses predict substantial growth for that nation's medical device markets; however, rarely do they provide hard data regarding epidemiological and procedure trends driving demand, the domestic health delivery system, domestic manufacturing capabilities, and cultural issues impacting medical device utilization. Health Research International's new report, "Opportunities in Chinese Cardiovascular Device Markets" fills this gap with a detailed analysis of cardiovascular epidemiology in China, procedure trends, profiles of leading cardiovascular hospitals, physicians and domestic suppliers, and cultural factors impacting health care in China. Available exclusively through Life Science Intelligence, the 244-page HRI report addresses the current and future status of interventional cardiology, cardiac surgery, and rhythm management in China. Nearly 100 exhibits address major procedures and product markets, including: PCI disposables, coronary stents, percutaneous defect repair technologies, cardiopulmonary bypass disposables, prosthetic heart valve products, endovascular aneurysm repair products, advanced electrophysiology systems and catheters, radiofrequency ablation systems and disposables, pacemakers and implantable cardioverter defibrillators. These exhibits and the market analyses include the results of a major survey of five leading Chinese hospitals regarding their cardiovascular procedures and products.
The report concludes that two factors will continue to drive developments in China's health care markets through 2013: continued, strict government control of the health delivery system, and continued observation of the Chinese virtue of "patience." Most Western observers are counting on the growth of foreign enterprise activity in China's medical device industry and the growing ability of many urban individuals to pay for improved health care to dramatically expand domestic demand. While this may be the case in the long-term, in the short-term, expansion and upgrading of the domestic delivery system will occur only gradually as the government balances cost issues, economic benefits, infrastructure development, and domestic production and export opportunities in its investment plans. China's skill at reverse engineering Western products is also a consideration as foreign companies seek to enter this market through joint ventures and subsidiary operations. Nevertheless, now is the window of opportunity to enter China and participate in both its health care growth and product markets. Even with the constraints identified, cardiovascular product sales are projected to increase 18% annually through 2013, attesting to the significant opportunity in China.EXECUTIVE SUMMARY
Health Care System
Cardiovascular Disease Epidemiology
Cardiovascular Procedures
Product Markets
Suppliers
Summary Exhibit 1: Trend in China's Population, 2007-2025
Summary Exhibit 2: Trend in Cardiac Hospital Admissions, 1948-2006
Summary Exhibit 3: Outlays on Major Cardiovascular Conditions & Diabetes, 2003
Summary Exhibit 4: Trend in Performance of Selected Cardiovascular Procedures, 2005-2013
Summary Exhibit 5: Cardiovascular Products, Market Forecast, 2005-2013
1.0 ECONOMY, POLITICS & CULTURE
1.1 Contemporary Society--Demographics & Culture
1.2 Economy
1.2.1 Private and Public Enterprises
1.2.2 World Trade Organization Accession
1.2.3 Foreign Economic Relations
1.2.4 Foreign Investment
Exhibit 1-1: Geography of Chinese Provinces
Exhibit 1-2: Chinese Population and Economy, 2007
Exhibit 1-3: China's GDP Relative to Selected Industrialized Nations, 2007
Exhibit 1-4: Trend in China GDP, 1999-2007
Exhibit 1-5: Chinese Import-Export Growth: 1999-2007
Exhibit 1-6: China's SEZs and Special Administrative Regions
2.0 CHINA'S HEALTHCARE SYSTEM
2.1 Structure
2.1.1 Historical Overview
2.1.2 Public & Private Hospitals
2.1.3 Hospital Grades and Classes
2.1.4 Health Insurance & Healthcare Reform
2.1.4.1 Rural Healthcare Reform
2.1.4.2 Urban Healthcare Reform: Insurance and Drugs
2.2 Personnel
2.2.1 Physicians
2.2.2 Nursing
2.2.3 Hospital Management
2.3 Level of Services
2.3.1 Grade 3 Services
2.3.2 Grade 2 Services
2.3.3 Grade 1 Services
2.4 Cardiovascular Resources in China
2.4.1 Profiles of Major Cardiovascular Hospitals
2.4.1.1 Dalian University, First Affiliated Hospital
2.4.1.2 China PLA Hospital
2.4.1.3 Guangdong Provincial People's Hospital
2.4.1.4 Huashan Hospital
2.4.1.5 Peking Union Medical College Hospital
2.4.1.6 Peking University Third Hospital
2.4.1.7 Shanghai Chest Hospital
2.4.1.8 Shenyang Northern Hospital
2.4.1.9 Wuhan Asia Heart Hospital
2.4.1.10 Wuhan Union Hospital of China
2.4.1.11 Xi'an Jiaotong Hospital
2.4.1.12 Xi'an Xijing Hospital
2.4.1.13 XinHua Hospital
2.4.2 Profiles of Major Cardiovascular Physicians
2.4.2.1 CHEN Haozhu
2.4.2.2 GAO Changqing
2.4.2.3 GAO Run-Lin
2.4.2.4 GE Junbo
2.4.2.5 GU Dongfeng
2.4.2.6 HAN Qide
2.4.2.7 HAN Yaling
2.4.2.8 HU Dayi
2.4.2.9 HU Shengshou
2.4.2.10 WAN Feng
2.4.2.11 WU Yangfeng
2.4.2.12 XU Zhiwei
2.4.2.13 ZHANG Baoren
2.4.2.14 ZHANG Youn
2.4.2.15 ZHAO Qiang
2.4.2.16 ZHU Xiaodong
2.4.3 Collaborative Research Projects with West
2.4.3.1 The China-U.S. Collaborative Project for Neural Tube Defect
2.4.3.2 PRC-USA Collaborative Study
2.4.3.3 The Sino-MONICA Project
2.4.3.4 The George Institute, China
2.4.3.5 InterASIA
Exhibit 2-1: Comparison of China & U.S. Healthcare Spending, 2004
Exhibit 2-2: Chinese Hospitalization Expense Structure, 2002
Exhibit 2-3: Average Hospital Expenditures by Region, 2005
Exhibit 2-4: Strengths and Weaknesses of Public versus Private Hospitals in China
Exhibit 2-5: Chinese Public Hospital Grading System
Exhibit 2-6: Distribution of China's Hospitals by Grade and Class, 2003
Exhibit 2-7: A Comparison of Chinese Insurance Plans
Exhibit 2-8: Chinese Urban Health Insurance Participation, 2003
Exhibit 2-9: Comparison of Chinese & U.S. Healthcare Personnel
Exhibit 2-10: Comparison of Services Offered by Hospital Grade
Exhibit 2-11: Selected Leading Cardiovascular Hospitals in China, 2007
Exhibit 2-12: Selected Leading Cardiovascular Physicians in China
Exhibit 2-13: Sino-MONICA Project Publications
Exhibit 2-14: George Institute, China Projects
Exhibit 2-15: Clinical Articles Incorporating InterASIA Data
3.0 CARDIOVASCULAR DISEASE IN CHINA
3.1 Coronary Heart Disease
3.2 Heart Failure
3.3 Cardiac Arrhythmias
3.4 Heart Valve Disease
3.5 Hypertension
3.6 Congenital Heart Defects
3.7 Chronic Pulmonary Heart Disease
3.8 Cardiovascular Disease Risk Factors
3.9 Medical Expenditures on Cardiovascular Diseases
Exhibit 3-1: Prevalence of Selected Chronic Diseases in China, 2003
Exhibit 3-2: Changing Patterns of Heart Disease in China, 1948-2006
Exhibit 3-3: Overview of Major Cardiovascular Disorders in China
Exhibit 3-4: Coronary Heart Disease Mortality, 2000 and 2004
Exhibit 3-5: Sales of Major Cardiovascular Drugs, 2003
Exhibit 3-6: Comparison of Left and Right-Sided Heart Failure
Exhibit 3-7: Selected Types of Arrhythmias
Exhibit 3-8: Chambers and Valves of the Heart
Exhibit 3-9: Rheumatic Heart Disease Mortality, 2002
Exhibit 3-10: Prevalence of Hypertension Among Population 15+ Years, 1959-2002
Exhibit 3-11: Prevalence Rates of Hypertension by Sex and Age
Exhibit 3-12: Prevalence of Hypertension by Setting, 2002
Exhibit 3-13: Major Congenital Heart Defects
Exhibit 3-14: Share of Chinese Population Considered Overweight, 1980-1998
Exhibit 3-15: Adult and Youth Cigarette Smoking Rates in China
Exhibit 3-16: Cigarette Consumption by Nation, 2004
Exhibit 3-17: Per Capita Cigarette Consumption in Selected Nations, 2004
Exhibit 3-18: Expenditures on Major Cardiovascular Conditions and Diabetes, 2003
4.0 CARDIOVASCULAR PROCEDURES & PRODUCTS
4.1 Profiles of Surveyed Hospitals
4.1.1 Beijing Anzhen Hospital
4.1.2 Beijing FuWai Heart Hospital & Cardiovascular Institute
4.1.3 Shanghai Changhai Hospital
4.1.4 Shanghai Ruijin Hospital
4.1.5 Shanghai Zhongshan Hospital
4.2 National Cardiovascular Facilities and Personnel
4.3 National Cardiovascular Procedure Data
4.3.1 Coronary Revascularization
4.3.2 Percutaneous Coronary Interventions and Stenting
4.3.3 Cardiac Surgery
4.3.3.1 Coronary Artery Bypass Graft Surgery
4.3.3.2 Heart Valve Surgery
4.3.3.3 Repair of Congenital Defects
4.3.4 Arrhythmia Management
4.3.4.1 Pacemaker Implantations
4.3.4.2 Implantable Cardioverter Defibrillators
4.3.4.3 Radiofrequency Ablation
4.3.5 Aneurysm Repairs
4.4 Product Markets and Suppliers
4.4.1 Interventional Cardiology Products
4.4.1.1 Coronary Angioplasty Disposables
4.4.1.2 Coronary Stents
4.1.1.3 Percutaneous Defect Repair Products
4.4.2 Heart Surgery Products
4.4.2.1 Open Heart Surgery Disposables
4.4.2.2 Prosthetic Heart Valves
4.4.2.3 Endovascular Stent-Grafts
4.4.3 Arrhythmia Products
4.4.3.1 Pacemakers
4.4.3.2 Implantable Cardioverter Defibrillators (ICDs)
4.4.3.3 Electrophysiology Products
4.4.3.3.1 Capital Equipment
4.4.3.3.2 AF Catheters
4.4.3.3.3 Standard Diagnostic Catheters
4.4.3.3.4 Standard Ablation Catheters
4.4.3.3.5 Suppliers
Exhibit 4-1: Selected Comparative Data on Five Surveyed Hospitals
Exhibit 4-2: Cardiovascular Procedure Data for Beijing Anzhen Hospital, 2002-2007
Exhibit 4-3: Cardiovascular Procedure Data for FuWai Heart Hospital & Cardiovascular Institute, 2002-2007
Exhibit 4-4: Cardiovascular Procedure Data for Shanghai Changhai Hospital, 2002-2007
Exhibit 4-5: Cardiovascular Procedure Data for Shanghai Ruijin Hospital, 2002-2007
Exhibit 4-6: Cardiovascular Procedure Data for Shanghai Zhongshan Hospital, 2002-2007
Exhibit 4-7: Estimated Cardiovascular Personnel and Facilities in China, 2007
Exhibit 4-8: Coronary Revascularization by Type, 2005-2013
Exhibit 4-9: PCI and Coronary Stenting, 2005-2013
Exhibit 4-10: Geographic Distribution of Cardiac Surgery in China, 2007
Exhibit 4-11: Cardiac & Aortic Surgeries by Major Type, 2005-2013
Exhibit 4-12: CABG Surgery by Approach, 2005-2013
Exhibit 4-13: Heart Valve Surgery by Position, 2005-2013
Exhibit 4-14: Heart Valve Surgery by Prosthesis Type, 2005-2013
Exhibit 4-15: Congenital Defect Repairs by Type, 2005-2013
Exhibit 4-16: Pacemaker Implantations, 2005-2013
Exhibit 4-17: Trend in ICDs Implanted by Type, 1997-2007
Exhibit 4-18: ICD Implantations, 2005-2013
Exhibit 4-19: Radiofrequency Catheter Ablations by Major Type, 2005-2013
Exhibit 4-20: Atrial Fibrillation Patients by Type and Etiology
Exhibit 4-21: Aortic Aneurysm Repairs, 2005-2013
Exhibit 4-22: Cardiovascular Products, Market Forecast, 2005-2013
Exhibit 4-23: PCI Disposables, Market Forecast, 2005-2013
Exhibit 4-24: Coronary Stents, Market Forecast, 2005-2013
Exhibit 4-25: Drug-Eluting Coronary Stents, Estimated Supplier Shares, 2006-2007
Exhibit 4-26: Percutaneous Congenital Defect Repair Products, Market Forecast, 2005-2013
Exhibit 4-27: Open Heart Surgery Disposables, Market Forecast, 2005-2013
Exhibit 4-28: Cardiopulmonary Bypass Disposables, Estimated Supplier Shares, 2007
Exhibit 4-29: Prosthetic Valves and Repair Products, Market Forecast, 2005-2013
Exhibit 4-30: Heart Valve Products, Estimated Supplier Shares, 2007
Exhibit 4-31: Endovascular Aneurysm Stent-Grafts, Market Forecast, 2005-2013
Exhibit 4-32: Endovascular Stent-Grafts, Estimated Supplier Shares, 2007
Exhibit 4-33: Pacemakers by Major Type, Market Forecast, 2005-2013
Exhibit 4-34: Pacemakers, Estimated Supplier Shares, 2007
Exhibit 4-35: ICDs, Market Forecast, 2005-2013
Exhibit 4-36: ICDs, Estimated Supplier Shares, 2007
Exhibit 4-37: Electrophysiology Products, Market Forecast, 2007-2013
Exhibit 4-38: Electrophysiology Capital Equipment, Market Forecast, 2005-2013
Exhibit 4-39: Atrial Fibrillation (AF) Catheters, Market Forecast, 2005-2013
Exhibit 4-40: Standard Diagnostic Catheters, Market Forecast, 2005-2013
Exhibit 4-41: Standard (Simple) Ablation Catheters, Market Forecast, 2005-2013
5.0 CHINA MEDICAL PRODUCTS INDUSTRY
5.1 Regulatory Issues
5.1.1 State Food & Drug Administration
5.1.1.1 Medical Device Classifications
5.1.1.2 SFDA Registration and Approval Procedures
5.1.1.3 Agents: Registration & After-Sales
5.1.1.4 SFDA Developments
5.1.2 Quality Supervision, Inspection and Quarantine
5.1.3 Ministry of Health & State-Owned Hospitals
5.2 Importing Medical Devices
5.2.1 Product Distribution
5.2.2 Distribution Services
5.2.3 Multi-Tiered Distribution
5.2.4 Potential Distributor Difficulties
5.2.5 Representative Offices
5.3 Product Manufacturing
5.3.1 Distributors versus Manufacturing
5.3.2 Product Manufacturing Options
5.3.2.1 Wholly Owned Foreign Enterprises
5.3.2.2 Joint Ventures
5.3.2.3 Outsourced Manufacturing
5.3.3 Geography of Medical Products Industry and Markets
5.4 Major Chinese Cardiovascular Device Companies
5.4.1 Beijing Lepu Medical
5.4.2 Dong Guan Ke Wei Medical Instrument Co.
5.4.3 JW Medical Systems
5.4.4 Lifetech (Shenzhen) Scientific
5.4.5 Microport Medical (Shanghai)
5.4.6 Tianjin Plastic Research Institute
Exhibit 5-1: Sample SFDA Registration Certificate
Exhibit 5-2: Medical Device Classifications
Exhibit 5-3: Guidelines and Procedures for SFDA Registration Requests
Exhibit 5-4: Accredited Medical Device Quality Supervision and Inspection Centers (MDQSIC)
Exhibit 5-5: Medical Devices Requiring CCC Certification and Sample Mark
Exhibit 5-6: CCC Mark Application Process
Exhibit 5-7: Select Chinese Medical Products Distributors
Exhibit 5-8: Potential Benefits and Dangers Associated with Chinese Distributors
Exhibit 5-9: Distributorship vs. Manufacturing Facility, Medical Products Sector
Exhibit 5-10: Chinese Manufacturing Options for Foreign Companies
Exhibit 5-11: Comparison of Foreign Direct Investment Options in China
Exhibit 5-12: Geography of China's Medical Industry and Markets
Exhibit 5-13: Selected Chinese Suppliers of Cardiovascular Devices, 2008
Company listing available upon request.
** Corporate License allows for report sharing within all company locations.
This report is listed in the following markets:
Cardiovascular and Procedure Volumes, Disease Incidence & Prevalence